Document Type : ResearchPaper


1 Aerospace Research Institute, Ministry of Science, Research and Technology

2 Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran

3 Department of Agricultural Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB)



Gravity is an influential force on living organisms on earth, including microorganisms. E. coli O157: H7 causes complications such as bloody diarrhea and hemolytic uremic syndrome in humans and immunization is the main way to fight it. Subunit B of Shiga-like toxin type 2 (STX2B), binding agent of bacterial toxin to target cells, is a candidate for the recombinant vaccine to prevent disease. Due to the quantitative and qualitative increase in the expression of some recombinant proteins under microgravity, the STX2B recombinant protein expression was examined under simulated microgravity conditions on clinostat device. After confirmation of the recombinant by immunological methods, its expression was performed under microgravity and after the protein purification by chromatographic column, its amount was measured. The results showed that despite the decrease in expression under microgravity, which was probably due to lack of proper aeration of the culture medium, recombinant protein was still produced under microgravity condition.


Main Subjects

  1. [1]    C.A. Nickerson,  and et al., "Microbial responses to microgravity and other low-shear environments." Microbiology and Molecular Biology Reviews, vol. 68, no. 2, p. 345-361, 2004.

    [2]    J. Huangfu,  and et al., "Omics analysis reveals the mechanism of enhanced recombinant protein production under simulated microgravity." Frontiers in bioengineering and biotechnology, vol. 8, p. 30, 2020.

    [3]    P.R. Murray, and K.S. Rosenthal, Review of medical microbiology, Elsevier Health Sciences. 2005.

    [4]    M. Rojas-Lopez, and et al., "Intestinal pathogenic Escherichia coli: Insights for vaccine development." Frontiers in microbiology, vol. 9, p. 440, 2018.

    [5]    N. Engedal, and et al., "Shiga toxin and its use in targeted cancer therapy and imaging." Microbial biotechnology, vol. 4, no. 1, p. 32-46, 2011.

    [6]    D.R. Sizemore, K.L. Roland, and U.S. Ryan, "Enterotoxigenic Escherichia coli virulence factors and vaccine approaches." Expert review of vaccines, vol. 3, no. 5, p. 585-595, 2004.

    [7]    J. Sánchez, and J. Holmgren, "Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea." Current opinion in immunology, vol. 17, no. 4, pp. 388-398, 2005.

    [8]    P. Saeedi, and et al., "Advances and challenges in recombinant protein expression in Escherichia coli." New Cellular and Molecular Biotechnology Journal, vol. 9, no. 36, pp. 9-42, 2019.

    [9]    B. Huang, and et al., "Effects of spaceflight and simulated microgravity on microbial growth and secondary metabolism." Military Medical Research,. vol. 5, no. 1, pp. 1-14, 2018.

    [10]  Y. Huang, and et al., "Enhanced S‐adenosyl‐l‐methionine production in Saccharomyces cerevisiae by spaceflight culture, overexpressing methionine adenosyltransferase and optimizing cultivation." Journal of applied microbiology, vol. 112, no. 4, pp. 683-694, 2012.

    [11]  L. Xiang, and et al., "Simulated microgravity affects growth of Escherichia coli and recombinant β-D-glucuronidase production." Applied biochemistry and biotechnology, vol. 162, no. 3, p. 654-661, 2010.

    [12]  F. Qi, and et al., "Enhancement of recombinant β‐D‐glucuronidase production under low‐shear modeled microgravity in Pichia pastoris." Journal of Chemical Technology & Biotechnology, 2011. vol. 86, no. 4, 2011, pp. 505-511.

    [13]  J. Huangfu, and et al., "Novel helper factors influencing recombinant protein production in Pichia pastoris based on proteomic analysis under simulated microgravity." Applied microbiology and biotechnology, vol. 99, no. 2, pp. 653-665, 2015.

    [14]  S. Navran, Rotary bioreactor for recombinant protein production, in Cell Technology for Cell Products, Springer, pp. 567-569, 2007.

    [15]  M.A. Saarinen, and D.W. Murhammer, "Culture in the rotating-wall vessel affects recombinant protein production capability of two insect cell lines in different manners." In Vitro Cellular & Developmental Biology-Animal, vol. 36, no. 6, pp. 362-366, 2000.

    [16]  R., G Willaert, "The growth behavior of the model eukaryotic yeast Saccharomyces cerevisiae in microgravity." Current Biotechnology, vol. 2, no. 3, pp. 226-234, 2013.

    [17]  G. Senatore, and et al., "Effect of microgravity & space radiation on microbes." Future microbiology, vol. 13, no. 07, pp. 831-847, 2018.

    [18] Z. Gitai, and L. Shapiro, "Bacterial cell division spirals into control." Proceedings of the National Academy of Sciences. vol. 100, no. 13, pp. 7423-7424, 2003.

    [19]  United Nations., Teacher’s Guide to Plant Experiments in Microgravity. Human Space Technology Initiative, 2013.

    1. Bollag, D. Michael, and J. Stuart, Protein methods, 2nd Ed. A John Willey and Sons. Inc. Pub., New York, 1996.

    [21]  P.T. Wingfield, I. Palmer, and S.M. "Liang, Folding and purification of insoluble (inclusion body) proteins from Escherichia coli." Current protocols in protein science, vol. 1, p. 6.5,1995.

    [22]  D.W. Carr, and J.D. Scott, Blotting and band-shifting: techniques for studying protein-protein interactions. Trends in biochemical sciences,. vol. 17, no. 7, pp. 246-249, 1992.

    [23]  T. San-Miguel, P. Pérez-Bermúdez, and I. Gavidia, Production of soluble eukaryotic recombinant proteins in E. coli is favoured in early log-phase cultures induced at low temperature. Springerplus, vol. 2, no. 1, pp. 1-4, 2013.

    [24]  R.G. Harrison, and M.J. Bagajewicz, "Predicting the solubility of recombinant proteins in Escherichia coli." Insoluble Proteins, p. 403-408, 2015.

    [25]  V.A. Garcia-Angulo, A. Kalita, and A.G. Torres, "Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection." Vaccine, vol. 31, no. 32, pp. 3229-3235, 2013.

    [26]  M.P. Stevens and et al., "Options for the control of enterohaemorrhagic Escherichia coli in ruminants." Microbiology, vol. 148, no. 12, pp. 3767-3778, 2002.

    [27]  R. Kazemi, and et al., "Cloning and expression of the binding subunit of shiga-like toxin type 2 gene and immunization study in an animal model." Pathobiology Research, vol.18, no. 4, p. 45-60. 2016

    [28]  Nelson, D., Lehninger principles of biochemistry Macmillan,  Lehninger principles of biochemistry: Macmillan, 2008.

    [29]  B. Muntari, and et al., "Recombinant bromelain production in Escherichia coli: process optimization in shake flask culture by response surface methodology." AMB express, vol. 2, no. 1, p.p. 1-9, 2012.